$CLB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CORE LABORATORIES N V.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CORE LABORATORIES N V. Get notifications about new insider transactions in CORE LABORATORIES N V for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2021 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Option Exercise | A | 0.00 | 4,307 | 0 | 4,307 | |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Option Exercise | M | 0.00 | 14,507 | 0 | 0 | |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Payment of Exercise | F | 30.10 | 6,746 | 203,055 | 11,181 | 17.9 K to 11.2 K (-37.63 %) |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Buy | M | 0.00 | 14,507 | 0 | 17,927 | 3.4 K to 17.9 K (+424.18 %) |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Klingensmith Harvey Robert | Director | Option Exercise | A | 0.00 | 4,307 | 0 | 4,307 | |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Klingensmith Harvey Robert | Director | Option Exercise | M | 0.00 | 14,507 | 0 | 0 | |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Klingensmith Harvey Robert | Director | Payment of Exercise | F | 30.10 | 73 | 2,197 | 16,434 | 16.5 K to 16.4 K (-0.44 %) |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Klingensmith Harvey Robert | Director | Buy | M | 0.00 | 14,507 | 0 | 16,507 | 2 K to 16.5 K (+725.35 %) |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Option Exercise | A | 0.00 | 4,307 | 0 | 4,307 | |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Option Exercise | M | 0.00 | 14,507 | 0 | 0 | |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Payment of Exercise | F | 30.10 | 73 | 2,197 | 20,800 | 20.9 K to 20.8 K (-0.35 %) |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Buy | M | 0.00 | 14,507 | 0 | 20,873 | 6.4 K to 20.9 K (+227.88 %) |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Barnett Gregory Barry | Director | Option Exercise | A | 0.00 | 4,307 | 0 | 4,307 | |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Barnett Gregory Barry | Director | Option Exercise | M | 0.00 | 14,507 | 0 | 0 | |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Barnett Gregory Barry | Director | Payment of Exercise | F | 30.10 | 73 | 2,197 | 29,600 | 29.7 K to 29.6 K (-0.25 %) |
Apr 05 2021 | CLB | CORE LABORATORIES ... | Barnett Gregory Barry | Director | Buy | M | 0.00 | 14,507 | 0 | 29,673 | 15.2 K to 29.7 K (+95.65 %) |
Mar 02 2021 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Option Exercise | M | 0.00 | 120 | 0 | 645 | |
Mar 02 2021 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Payment of Exercise | F | 36.84 | 55 | 2,026 | 2,429 | 2.5 K to 2.4 K (-2.21 %) |
Mar 02 2021 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Buy | M | 0.00 | 120 | 0 | 2,484 | 2.4 K to 2.5 K (+5.08 %) |
Feb 23 2021 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Option Exercise | A | 0.00 | 7,200 | 0 | 7,200 | |
Feb 23 2021 | CLB | CORE LABORATORIES ... | Elvig Mark F | SVP, Gen Counsel & ... | Option Exercise | A | 0.00 | 6,900 | 0 | 6,900 | |
Feb 23 2021 | CLB | CORE LABORATORIES ... | Elvig Mark F | SVP, Gen Counsel & ... | Option Exercise | A | 0.00 | 6,900 | 0 | 6,900 | |
Feb 23 2021 | CLB | CORE LABORATORIES ... | Schreffler Gwendolyn | SVP | Option Exercise | A | 0.00 | 13,810 | 0 | 13,810 | |
Feb 23 2021 | CLB | CORE LABORATORIES ... | Schreffler Gwendolyn | SVP | Option Exercise | A | 0.00 | 13,810 | 0 | 13,810 | |
Feb 23 2021 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | SVP & CFO | Option Exercise | A | 0.00 | 33,950 | 0 | 33,950 | |
Feb 23 2021 | CLB | CORE LABORATORIES ... | Bruno Lawrence | Chairman and CEO | Option Exercise | A | 0.00 | 94,172 | 0 | 94,172 | |
Feb 23 2021 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | SVP & CFO | Option Exercise | A | 0.00 | 33,950 | 0 | 33,950 | |
Feb 23 2021 | CLB | CORE LABORATORIES ... | Bruno Lawrence | Chairman and CEO | Option Exercise | A | 0.00 | 94,172 | 0 | 94,172 | |
Jan 05 2021 | CLB | CORE LABORATORIES ... | Elvig Mark F | SVP, Gen Counsel & ... | Option Exercise | M | 0.00 | 2,600 | 0 | 0 | |
Jan 05 2021 | CLB | CORE LABORATORIES ... | Elvig Mark F | SVP, Gen Counsel & ... | Payment of Exercise | F | 26.51 | 454 | 12,036 | 12,442 | 12.9 K to 12.4 K (-3.52 %) |
Jan 05 2021 | CLB | CORE LABORATORIES ... | Elvig Mark F | SVP, Gen Counsel & ... | Sell | J | 0.00 | 739 | 0 | 12,896 | 13.6 K to 12.9 K (-5.42 %) |
Jan 05 2021 | CLB | CORE LABORATORIES ... | Elvig Mark F | SVP, Gen Counsel & ... | Buy | M | 0.00 | 2,600 | 0 | 13,635 | 11 K to 13.6 K (+23.56 %) |
Jan 05 2021 | CLB | CORE LABORATORIES ... | Bruno Lawrence | Chairman and CEO | Option Exercise | M | 0.00 | 13,682 | 0 | 0 | |
Jan 05 2021 | CLB | CORE LABORATORIES ... | Bruno Lawrence | Chairman and CEO | Payment of Exercise | F | 26.51 | 5,384 | 142,730 | 19,158 | 24.5 K to 19.2 K (-21.94 %) |
Jan 05 2021 | CLB | CORE LABORATORIES ... | Bruno Lawrence | Chairman and CEO | Buy | M | 0.00 | 13,682 | 0 | 24,542 | 10.9 K to 24.5 K (+125.99 %) |
Jun 23 2020 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP,Counsel & Secret ... | Sell | J | 0.00 | 1,323 | 0 | 1,245 | 2.6 K to 1.2 K (-51.52 %) |
May 20 2020 | CLB | CORE LABORATORIES ... | van Dijken Eeuwijk Monique | Director | Option Exercise | A | 0.00 | 14,507 | 0 | 14,507 | |
May 19 2020 | CLB | CORE LABORATORIES ... | GOLDMAN SACHS GROUP INC | Option Exercise | P | 0.00 | 93 | 0 | 93 | ||
May 19 2020 | CLB | CORE LABORATORIES ... | GOLDMAN SACHS GROUP INC | Option Exercise | S | 0.00 | 1,176 | 0 | 1,176 | ||
May 19 2020 | CLB | CORE LABORATORIES ... | GOLDMAN SACHS GROUP INC | Buy | P | 9.25 | 300 | 2,775 | 4,640,900 | 4.6 M to 4.6 M (+0.01 %) | |
May 19 2020 | CLB | CORE LABORATORIES ... | GOLDMAN SACHS GROUP INC | Buy | P | 9.41 | 376 | 3,538 | 4,640,600 | 4.6 M to 4.6 M (+0.01 %) | |
Apr 02 2020 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Option Exercise | A | 0.00 | 14,507 | 0 | 14,507 | |
Apr 02 2020 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Option Exercise | M | 0.00 | 2,177 | 0 | 0 | |
Apr 02 2020 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Payment of Exercise | F | 9.49 | 1,078 | 10,230 | 5,497 | 6.6 K to 5.5 K (-16.40 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Buy | M | 0.00 | 2,177 | 0 | 6,575 | 4.4 K to 6.6 K (+49.50 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Option Exercise | A | 0.00 | 14,507 | 0 | 14,507 | |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Option Exercise | M | 0.00 | 2,177 | 0 | 0 | |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Payment of Exercise | F | 9.49 | 1,013 | 9,613 | 3,420 | 4.4 K to 3.4 K (-22.85 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Buy | M | 0.00 | 2,177 | 0 | 4,433 | 2.3 K to 4.4 K (+96.50 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Option Exercise | A | 0.00 | 14,507 | 0 | 14,507 | |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Option Exercise | M | 0.00 | 2,177 | 0 | 0 | |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Payment of Exercise | F | 9.49 | 1,078 | 10,230 | 7,252 | 8.3 K to 7.3 K (-12.94 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Buy | M | 0.00 | 2,177 | 0 | 8,330 | 6.2 K to 8.3 K (+35.38 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | SVP & CFO | Option Exercise | M | 0.00 | 53 | 0 | 0 | |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | SVP & CFO | Payment of Exercise | F | 9.49 | 24 | 228 | 15,108 | 15.1 K to 15.1 K (-0.16 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | SVP & CFO | Buy | M | 0.00 | 53 | 0 | 15,132 | 15.1 K to 15.1 K (+0.35 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Option Exercise | M | 0.00 | 70 | 0 | 1,010 | |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Payment of Exercise | F | 9.49 | 32 | 304 | 644 | 676 to 644 (-4.73 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Buy | M | 0.00 | 70 | 0 | 676 | 606 to 676 (+11.55 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Option Exercise | A | 0.00 | 14,507 | 0 | 14,507 | |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Option Exercise | M | 0.00 | 2,177 | 0 | 0 | |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Payment of Exercise | F | 9.49 | 11 | 104 | 6,366 | 6.4 K to 6.4 K (-0.17 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Buy | M | 0.00 | 2,177 | 0 | 6,377 | 4.2 K to 6.4 K (+51.83 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President & COO | Option Exercise | M | 0.00 | 100 | 0 | 0 | |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President & COO | Payment of Exercise | F | 9.49 | 39 | 370 | 10,860 | 10.9 K to 10.9 K (-0.36 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President & COO | Buy | M | 0.00 | 100 | 0 | 10,899 | 10.8 K to 10.9 K (+0.93 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Barnett Gregory Barry | Director | Option Exercise | A | 0.00 | 14,507 | 0 | 14,507 | |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Barnett Gregory Barry | Director | Option Exercise | M | 0.00 | 2,177 | 0 | 0 | |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Barnett Gregory Barry | Director | Payment of Exercise | F | 9.49 | 11 | 104 | 15,166 | 15.2 K to 15.2 K (-0.07 %) |
Apr 02 2020 | CLB | CORE LABORATORIES ... | Barnett Gregory Barry | Director | Buy | M | 0.00 | 2,177 | 0 | 15,177 | 13 K to 15.2 K (+16.75 %) |
Mar 03 2020 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Option Exercise | M | 0.00 | 120 | 0 | 1,080 | |
Mar 03 2020 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Payment of Exercise | F | 26.84 | 54 | 1,449 | 606 | 660 to 606 (-8.18 %) |
Mar 03 2020 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Buy | M | 0.00 | 120 | 0 | 660 | 540 to 660 (+22.22 %) |
Feb 12 2020 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President & COO | Option Exercise | A | 0.00 | 91,212 | 0 | 91,212 | |
Feb 12 2020 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | SVP & CFO | Option Exercise | A | 0.00 | 31,688 | 0 | 31,688 | |
Feb 12 2020 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP,Counsel & Secret ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Feb 12 2020 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Option Exercise | A | 0.00 | 144,606 | 0 | 144,606 | |
Feb 04 2020 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President & COO | Buy | P | 34.60 | 1,000 | 34,600 | 10,799 | 9.8 K to 10.8 K (+10.21 %) |
Feb 04 2020 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President & COO | Buy | P | 34.98 | 1,000 | 34,979 | 9,799 | 8.8 K to 9.8 K (+11.36 %) |
Feb 04 2020 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President & COO | Buy | P | 35.00 | 1,000 | 35,000 | 8,799 | 7.8 K to 8.8 K (+12.82 %) |
Jan 03 2020 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | SVP & CFO | Option Exercise | M | 0.00 | 2,400 | 0 | 0 | |
Jan 03 2020 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | SVP & CFO | Payment of Exercise | F | 37.67 | 945 | 35,598 | 15,079 | 16 K to 15.1 K (-5.90 %) |
Jan 03 2020 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | SVP & CFO | Buy | M | 0.00 | 2,400 | 0 | 16,024 | 13.6 K to 16 K (+17.62 %) |
Jan 03 2020 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President & COO | Option Exercise | M | 0.00 | 2,400 | 0 | 0 | |
Jan 03 2020 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President & COO | Payment of Exercise | F | 37.67 | 945 | 35,598 | 7,799 | 8.7 K to 7.8 K (-10.81 %) |
Jan 03 2020 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President & COO | Buy | M | 0.00 | 2,400 | 0 | 8,744 | 6.3 K to 8.7 K (+37.83 %) |
Jan 03 2020 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Option Exercise | M | 0.00 | 59,100 | 0 | 0 | |
Jan 03 2020 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Payment of Exercise | F | 37.67 | 19,274 | 726,052 | 365,844 | 385.1 K to 365.8 K (-5.00 %) |
Jan 03 2020 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Buy | M | 0.00 | 59,100 | 0 | 385,118 | 326 K to 385.1 K (+18.13 %) |
Dec 03 2019 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Option Exercise | M | 0.00 | 140 | 0 | 1,200 | |
Dec 03 2019 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Payment of Exercise | F | 43.80 | 54 | 2,365 | 540 | 594 to 540 (-9.09 %) |
Dec 03 2019 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Buy | M | 0.00 | 140 | 0 | 594 | 454 to 594 (+30.84 %) |
Aug 15 2019 | CLB | CORE LABORATORIES ... | Barnett Gregory Barry | Director | Buy | P | 38.00 | 2,000 | 76,000 | 13,000 | 11 K to 13 K (+18.18 %) |
Aug 15 2019 | CLB | CORE LABORATORIES ... | Barnett Gregory Barry | Director | Buy | P | 38.00 | 2,000 | 76,000 | 13,000 | 11 K to 13 K (+18.18 %) |
Aug 15 2019 | CLB | CORE LABORATORIES ... | Barnett Gregory Barry | Director | Buy | P | 40.00 | 1,000 | 40,000 | 11,000 | 10 K to 11 K (+10.00 %) |
Aug 15 2019 | CLB | CORE LABORATORIES ... | Barnett Gregory Barry | Director | Buy | P | 40.00 | 1,000 | 40,000 | 11,000 | 10 K to 11 K (+10.00 %) |
Jul 03 2019 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Option Exercise | M | 0.00 | 105 | 0 | 1,340 | |
Jul 03 2019 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Payment of Exercise | F | 52.88 | 41 | 2,168 | 454 | 495 to 454 (-8.28 %) |
Jul 03 2019 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Buy | M | 0.00 | 105 | 0 | 495 | 390 to 495 (+26.92 %) |
May 28 2019 | CLB | CORE LABORATORIES ... | Barnett Gregory Barry | Director | Option Exercise | A | 0.00 | 2,177 | 0 | 2,177 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Option Exercise | A | 0.00 | 2,177 | 0 | 2,177 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Option Exercise | M | 0.00 | 1,387 | 0 | 0 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Option Exercise | M | 0.00 | 1,335 | 0 | 0 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Payment of Exercise | F | 68.93 | 722 | 49,767 | 6,153 | 6.9 K to 6.2 K (-10.50 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Buy | M | 0.00 | 1,387 | 0 | 6,875 | 5.5 K to 6.9 K (+25.27 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Payment of Exercise | F | 68.93 | 695 | 47,906 | 5,488 | 6.2 K to 5.5 K (-11.24 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Buy | M | 0.00 | 1,335 | 0 | 6,183 | 4.8 K to 6.2 K (+27.54 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | SVP and CFO | Option Exercise | M | 0.00 | 53 | 0 | 53 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | SVP and CFO | Payment of Exercise | F | 68.93 | 25 | 1,723 | 13,624 | 13.6 K to 13.6 K (-0.18 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | SVP and CFO | Buy | M | 0.00 | 53 | 0 | 13,649 | 13.6 K to 13.6 K (+0.39 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President | Option Exercise | M | 0.00 | 100 | 0 | 100 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President | Payment of Exercise | F | 68.93 | 46 | 3,171 | 6,344 | 6.4 K to 6.3 K (-0.72 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President | Buy | M | 0.00 | 100 | 0 | 6,390 | 6.3 K to 6.4 K (+1.59 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President | Grant | A | 0.00 | 100 | 0 | 6,290 | 6.4 K to 6.3 K (-1.56 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Option Exercise | A | 0.00 | 2,177 | 0 | 2,177 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Option Exercise | M | 0.00 | 1,387 | 0 | 0 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Option Exercise | M | 0.00 | 1,335 | 0 | 0 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Payment of Exercise | F | 68.93 | 722 | 49,767 | 4,398 | 5.1 K to 4.4 K (-14.10 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Buy | M | 0.00 | 1,387 | 0 | 5,120 | 3.7 K to 5.1 K (+37.16 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Payment of Exercise | F | 68.93 | 695 | 47,906 | 3,733 | 4.4 K to 3.7 K (-15.70 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Buy | M | 0.00 | 1,335 | 0 | 4,428 | 3.1 K to 4.4 K (+43.16 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Option Exercise | A | 0.00 | 2,177 | 0 | 2,177 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Option Exercise | M | 0.00 | 1,387 | 0 | 0 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Option Exercise | M | 0.00 | 1,335 | 0 | 0 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Payment of Exercise | F | 68.93 | 7 | 483 | 4,200 | 4.2 K to 4.2 K (-0.17 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Buy | M | 0.00 | 1,387 | 0 | 4,207 | 2.8 K to 4.2 K (+49.18 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Payment of Exercise | F | 68.93 | 7 | 483 | 2,820 | 2.8 K to 2.8 K (-0.25 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Carnes Martha Z. | Director | Buy | M | 0.00 | 1,335 | 0 | 2,827 | 1.5 K to 2.8 K (+89.48 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Option Exercise | M | 0.00 | 1,387 | 0 | 0 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Option Exercise | M | 0.00 | 1,335 | 0 | 0 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Payment of Exercise | F | 68.93 | 7 | 483 | 8,062 | 8.1 K to 8.1 K (-0.09 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Buy | M | 0.00 | 1,387 | 0 | 8,069 | 6.7 K to 8.1 K (+20.76 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Payment of Exercise | F | 68.93 | 7 | 483 | 6,682 | 6.7 K to 6.7 K (-0.10 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Buy | M | 0.00 | 1,335 | 0 | 6,689 | 5.4 K to 6.7 K (+24.93 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Option Exercise | A | 0.00 | 2,177 | 0 | 2,177 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Option Exercise | M | 0.00 | 1,387 | 0 | 0 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Option Exercise | M | 0.00 | 1,335 | 0 | 0 | |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Payment of Exercise | F | 68.93 | 645 | 44,460 | 2,256 | 2.9 K to 2.3 K (-22.23 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Buy | M | 0.00 | 1,387 | 0 | 2,901 | 1.5 K to 2.9 K (+91.61 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Payment of Exercise | F | 68.93 | 621 | 42,806 | 1,514 | 2.1 K to 1.5 K (-29.09 %) |
Apr 02 2019 | CLB | CORE LABORATORIES ... | Straughen Michael | Director | Buy | M | 0.00 | 1,335 | 0 | 2,135 | 800 to 2.1 K (+166.88 %) |
Mar 12 2019 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Sell | S | 66.25 | 428 | 28,355 | 352 | 780 to 352 (-54.87 %) |
Mar 05 2019 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Option Exercise | M | 0.00 | 120 | 0 | 1,515 | |
Mar 05 2019 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Option Exercise | M | 0.00 | 110 | 0 | 1,635 | |
Mar 05 2019 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Payment of Exercise | F | 67.37 | 54 | 3,638 | 780 | 834 to 780 (-6.47 %) |
Mar 05 2019 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Buy | M | 0.00 | 120 | 0 | 834 | 714 to 834 (+16.81 %) |
Mar 05 2019 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Payment of Exercise | F | 67.37 | 50 | 3,369 | 714 | 764 to 714 (-6.54 %) |
Mar 05 2019 | CLB | CORE LABORATORIES ... | Daniels Kevin | CAO & Treasurer | Buy | M | 0.00 | 110 | 0 | 764 | 654 to 764 (+16.82 %) |
Feb 14 2019 | CLB | CORE LABORATORIES ... | Bruno Lawrence | President | Option Exercise | A | 0.00 | 30,822 | 0 | 30,822 | |
Feb 14 2019 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | SVP and CFO | Option Exercise | A | 0.00 | 15,684 | 0 | 15,684 |